• Explore /
  • Poster
  • / Tazemetostat in patients with tumors with alterations in EZH2 or the SWI/SNF complex: Results from NCI-COG Pediatric MATCH trial Arm C (APEC1621C).

Tazemetostat in patients with tumors with alterations in EZH2 or the SWI/SNF complex: Results from NCI-COG Pediatric MATCH trial Arm C (APEC1621C).

Abstract Video & Slides Poster

Authors

Susan Chi

Susan N. Chi

Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA

Susan N. Chi , Joanna S. Yi , P. Mickey Williams , Sinchita Roy-Chowdhuri , David R. Patton , Brent Coffey , Joel M. Reid , Jin Piao , Lauren Saguilig , Todd Allen Alonzo , Stacey L. Berg , Joyce Mhlanga , Elizabeth Fox , Douglas S. Hawkins , Margaret M. Mooney , Naoko Takebe , James V. Tricoli , Katherine A. Janeway , Nita Seibel , Donald Williams Parsons

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Pediatric Oncology

Track

Pediatric Oncology

Sub Track

Pediatric Solid Tumors

Clinical Trial Registration Number

NCT03213665

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 10009)

DOI

10.1200/JCO.2022.40.16_suppl.10009

Abstract #

10009

Poster Bd #

224

Abstract Disclosures

Similar Posters

First Author: Susan N. Chi

First Author: Susan N. Chi

First Author: Joanna S. Yi

First Author: Mark Agulnik